Danny Manor
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Danny Manor has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Jeffrey Atkinson
Department of Chemistry, Brock University, Ontario, Canada
8 shared publications Samantha Morley
§Cornell University, Ithaca, New York 14853
4 shared publicationsVarsha Thakur
Case Western Reserve University
4 shared publications- Lynn Ulatowski
Department of Biology, Ursuline College, Pepper Pike, Ohio, USA
3 shared publications Mikel Ghelfi
Department of Chemistry, Brock University, Ontario, Canada
3 shared publicationsStacey Chung
Department of Nutrition, Case Western Reserve University, Cleveland, Ohio, USA
3 shared publications
Latest Publications
- Open Access
- 6 May 2026
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 109, 101477
Beyond 100 years of vitamin E and related molecules – Milestones and open challenges
- 6 May 2026
- Published by Elsevier in Molecular Aspects of Medicine
- Vol. 109, 101477
Open AccessBeyond 100 years of vitamin E and related molecules – Milestones and open challenges
- Open Access
- 18 February 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (4) , 108327
Antioxidant-independent activities of alpha-tocopherol
- 18 February 2025
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (4) , 108327
Open AccessAntioxidant-independent activities of alpha-tocopherol
- Open Access
- 9 February 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (3) , 101712
The tocopherol transfer protein mediates vitamin E trafficking between cerebellar astrocytes and neurons
- 9 February 2022
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 298 (3) , 101712
Open AccessThe tocopherol transfer protein mediates vitamin E trafficking between cerebellar astrocytes and neurons
- Open Access
- 13 August 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (16) , 5808
Adenovirus Reveals New Pathway for Cholesterol Egress from the Endolysosomal System
In addition to providing invaluable insights to the host response to viral infection, adenovirus continues to be an important model system for discovering basic aspects of cell biology. This is especially true for products of early region three (E3), which have provided the foundation for understanding many new mechanisms regulating intracellular trafficking of host cell proteins involved in the host immune response. Cholesterol homeostasis is vital for proper cellular physiology, and disturbances in cholesterol balance are increasingly recognized as important factors in human disease. Despite its central role in numerous aspects of cellular functions, the mechanisms responsible for delivery of dietary cholesterol to the endoplasmic reticulum, where the lipid metabolic and regulatory machinery reside, remain poorly understood. In this review, we describe a novel intracellular pathway for cholesterol trafficking that has been co-opted by an adenovirus E3 gene product. We describe what is known about the molecular regulation of this pathway, how it might benefit viral replication, and its potential involvement in normal cell physiology. Finally, we make a case that adenovirus has co-opted a cellular pathway that may be dysregulated in various human diseases.
- 13 August 2020
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 21 (16) , 5808
Open AccessAdenovirus Reveals New Pathway for Cholesterol Egress from the Endolysosomal System
In addition to providing invaluable insights to the host response to viral infection, adenovirus continues to be an important model system for discovering basic aspects of cell biology. This is especially true for products of early region three (E3), which have provided the foundation for understanding many new mechanisms regulating intracellular trafficking of host cell proteins involved in the host immune response. Cholesterol homeostasis is vital for proper cellular physiology, and disturbances in cholesterol balance are increasingly recognized as important factors in human disease. Despite its central role in numerous aspects of cellular functions, the mechanisms responsible for delivery of dietary cholesterol to the endoplasmic reticulum, where the lipid metabolic and regulatory machinery reside, remain poorly understood. In this review, we describe a novel intracellular pathway for cholesterol trafficking that has been co-opted by an adenovirus E3 gene product. We describe what is known about the molecular regulation of this pathway, how it might benefit viral replication, and its potential involvement in normal cell physiology. Finally, we make a case that adenovirus has co-opted a cellular pathway that may be dysregulated in various human diseases.
- Open Access
- 16 January 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (1)
Vitamin E sequestration by liver fat in humans
BACKGROUND: We hypothesized that obesity-associated hepatosteatosis is a pathophysiological chemical depot for fat-soluble vitamins and altered normal physiology. Using α-tocopherol (vitamin E) as a model vitamin, pharmacokinetics and kinetics principles were used to determine whether excess liver fat sequestered α-tocopherol in women with obesity-associated hepatosteatosis versus healthy controls. METHODS: Custom-synthesized deuterated α-tocopherols (d 3 - and d 6 -α-tocopherols) were administered to hospitalized healthy women and women with hepatosteatosis under investigational new drug guidelines. Fluorescently labeled α-tocopherol was custom-synthesized for cell studies. RESULTS: In healthy subjects, 85% of intravenous d 6 -α-tocopherol disappeared from the circulation within 20 minutes but reappeared within minutes and peaked at 3–4 hours; d 3 - and d 6 -α-tocopherols localized to lipoproteins. Lipoprotein redistribution occurred only in vivo within 1 hour, indicating a key role of the liver in uptake and re-release. Compared with healthy subjects who received 2 mg, subjects with hepatosteatosis had similar d 6 -α-tocopherol entry rates into liver but reduced initial release rates ( P < 0.001). Similarly, pharmacokinetics parameters were reduced in hepatosteatosis subjects, indicating reduced hepatic d 6 -α-tocopherol output. Reductions in kinetics and pharmacokinetics parameters in hepatosteatosis subjects who received 2 mg were echoed by similar reductions in healthy subjects when comparing 5- and 2-mg doses. In vitro, fluorescent-labeled α-tocopherol localized to lipid in fat-loaded hepatocytes, indicating sequestration. CONCLUSIONS: The unique role of the liver in vitamin E physiology is dysregulated by excess liver fat. Obesity-associated hepatosteatosis may produce unrecognized hepatic vitamin E sequestration, which might subsequently drive liver disease. Our findings raise the possibility that hepatosteatosis may similarly alter hepatic physiology of other fat-soluble vitamins. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00862433. FUNDING: National Institute of Diabetes and Digestive and Kidney Diseases and NIH grants DK053213-13, DK067494, and DK081761.
- 16 January 2020
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 5 (1)
Open AccessVitamin E sequestration by liver fat in humans
BACKGROUND: We hypothesized that obesity-associated hepatosteatosis is a pathophysiological chemical depot for fat-soluble vitamins and altered normal physiology. Using α-tocopherol (vitamin E) as a model vitamin, pharmacokinetics and kinetics principles were used to determine whether excess liver fat sequestered α-tocopherol in women with obesity-associated hepatosteatosis versus healthy controls. METHODS: Custom-synthesized deuterated α-tocopherols (d 3 - and d 6 -α-tocopherols) were administered to hospitalized healthy women and women with hepatosteatosis under investigational new drug guidelines. Fluorescently labeled α-tocopherol was custom-synthesized for cell studies. RESULTS: In healthy subjects, 85% of intravenous d 6 -α-tocopherol disappeared from the circulation within 20 minutes but reappeared within minutes and peaked at 3–4 hours; d 3 - and d 6 -α-tocopherols localized to lipoproteins. Lipoprotein redistribution occurred only in vivo within 1 hour, indicating a key role of the liver in uptake and re-release. Compared with healthy subjects who received 2 mg, subjects with hepatosteatosis had similar d 6 -α-tocopherol entry rates into liver but reduced initial release rates ( P < 0.001). Similarly, pharmacokinetics parameters were reduced in hepatosteatosis subjects, indicating reduced hepatic d 6 -α-tocopherol output. Reductions in kinetics and pharmacokinetics parameters in hepatosteatosis subjects who received 2 mg were echoed by similar reductions in healthy subjects when comparing 5- and 2-mg doses. In vitro, fluorescent-labeled α-tocopherol localized to lipid in fat-loaded hepatocytes, indicating sequestration. CONCLUSIONS: The unique role of the liver in vitamin E physiology is dysregulated by excess liver fat. Obesity-associated hepatosteatosis may produce unrecognized hepatic vitamin E sequestration, which might subsequently drive liver disease. Our findings raise the possibility that hepatosteatosis may similarly alter hepatic physiology of other fat-soluble vitamins. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00862433. FUNDING: National Institute of Diabetes and Digestive and Kidney Diseases and NIH grants DK053213-13, DK067494, and DK081761.
- 2 April 2019
- Published by Springer Nature
- p. 111-124
The Tocopherol Transfer Protein: Regulator of Vitamin E Status
- 2 April 2019
- Published by Springer Nature
- p. 111-124
The Tocopherol Transfer Protein: Regulator of Vitamin E Status
- Open Access
- 1 August 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (33) , 17028-17039
Vitamin E and Phosphoinositides Regulate the Intracellular Localization of the Hepatic α-Tocopherol Transfer Protein
- 1 August 2016
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 291 (33) , 17028-17039
Open AccessVitamin E and Phosphoinositides Regulate the Intracellular Localization of the Hepatic α-Tocopherol Transfer Protein
- 1 December 2015
- Published by Elsevier in Neurobiology of Disease
- Vol. 84, 78-83
Vitamin E and neurodegeneration
- 1 December 2015
- Published by Elsevier in Neurobiology of Disease
- Vol. 84, 78-83
Vitamin E and neurodegeneration
- Open Access
- 1 June 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (24) , 17195-17202
Tyrosine Phosphorylation of Dbl Regulates GTPase Signaling
- 1 June 2014
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 289 (24) , 17195-17202
Open AccessTyrosine Phosphorylation of Dbl Regulates GTPase Signaling
- 1 February 2014
- Published by Elsevier in Neuroscience
- Vol. 260, 120-129
Vitamin E is essential for Purkinje neuron integrity
- 1 February 2014
- Published by Elsevier in Neuroscience
- Vol. 260, 120-129
Vitamin E is essential for Purkinje neuron integrity